Year: 2020

Achieve Life Sciences, University of Bristol, and Oracle Corporation Announce Study Results Demonstrating Potential for Accelerated Speed of Drug Discovery

SEATTLE and VANCOUVER, British Columbia, Jan. 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), University of Bristol, and Oracle...

Arcutis Announces Exercise of Option for Exclusive License to Highly Selective JAK1 Inhibitor for All Topical Dermatological Uses in U.S., Canada, Europe and Japan

ARQ-252 potential to offer "Best in Class" topical JAK therapy Phase 2b study in adult patients with hand eczema anticipated...

error: Content is protected !!